Neurodevelopmental sequelae of pediatric acute lymphoblastic leukemia and its treatment.
D000293:Adolescent; D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D001921:Brain / Q000187:drug effects / Q000528:radiation effects; D001925:Brain Damage, Chronic / Q000139:chemically induced* / Q000175:diagnosis / Q000523:psychology; D002648:Child; D002675:Child, Preschool; D003072:Cognition Disorders / Q000139:chemically induced* / Q000175:diagnosis / Q000523:psychology; D003131:Combined Modality Therapy; D016371:Cranial Irradiation; D002658:Developmental Disabilities / Q000139:chemically induced* / Q000175:diagnosis / Q000523:psychology; D006801:Humans; D007223:Infant; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy* / Q000532:radiotherapy; D011379:Prognosis; D011832:Radiation Injuries / Q000175:diagnosis / Q000523:psychology; D017741:Survivors / Q000523:psychology*; D016896:Treatment Outcome; D055815:Young Adult